Profiling the effects of rifaximin on the healthy human colonic microbiota using a chemostat model
I. B. Moura, A. M. Buckley, D. Ewin, E. Clark, S. Mitra, M. H. Wilcox, C. H. Chilton
This study evaluates three rifaximin formulations on the human colonic microbiota using chemostat models, finding that formulation {kappa} caused the least disruption.
bioRxiv · Nov 1, 2019 · PreprintMicrobiology